Overall Status

Recruiting (3)

Active, not recruiting (2)

Sign in for free

Phase

phase 1 (2)

n/a (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Brian Druker (1)

Children's Oncology Group (1)

Kronos Bio (1)

LLS PedAL Initiative, LLC (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (2)

AbbVie (1)

Children's Oncology Group (1)

Incyte Corporation (1)

Oregon Health and Science University (1)

Intervention

belinostat (1)

biospecimen collection (1)

enasidenib (1)

enasidenib mesylate (1)

gilteritinib (1)

lanraplenib (1)

pevonedistat (1)

ruxolitinib (1)

venetoclax (1)

Study Documents

Intervention Type

drug (4)

procedure (1)

Funder Type

Other (3)

Industry (1)

NIH (1)

Study Type

Interventional (5)

Refractory Acute Myeloid Leukemia

Showing NaN - NaN of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS